Pharmagest Interactive SA
F:PHF

Watchlist Manager

Pharmagest Interactive SA

F:PHF

Watchlist

Dividends

Discount Rate

Price: 45.65 EUR 1.44% Market Closed

Market Cap: 686.3m EUR

Have any thoughts about
Pharmagest Interactive SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 45.65 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

PHF Alert

Pharmagest Interactive SA

45.65

+0.65 (+1.44%)

52 Week Range	44.55 65.6
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Pharmagest Interactive SA

What unique competitive advantages
does Pharmagest Interactive SA hold over its rivals?

What risks and challenges
does Pharmagest Interactive SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Pharmagest Interactive SA.

What unique competitive advantages
does Pharmagest Interactive SA hold over its rivals?

What risks and challenges
does Pharmagest Interactive SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pharmagest Interactive SA.

Provide P/S
for Pharmagest Interactive SA.

Provide P/E
for Pharmagest Interactive SA.

Provide P/OCF
for Pharmagest Interactive SA.

Provide P/FCFE
for Pharmagest Interactive SA.

Provide P/B
for Pharmagest Interactive SA.

Provide EV/S
for Pharmagest Interactive SA.

Provide EV/GP
for Pharmagest Interactive SA.

Provide EV/EBITDA
for Pharmagest Interactive SA.

Provide EV/EBIT
for Pharmagest Interactive SA.

Provide EV/OCF
for Pharmagest Interactive SA.

Provide EV/FCFF
for Pharmagest Interactive SA.

Provide EV/IC
for Pharmagest Interactive SA.

Show me price targets
for Pharmagest Interactive SA made by professional analysts.

What are the Revenue projections
for Pharmagest Interactive SA?

How accurate were the past Revenue estimates
for Pharmagest Interactive SA?

What are the Net Income projections
for Pharmagest Interactive SA?

How accurate were the past Net Income estimates
for Pharmagest Interactive SA?

What are the EPS projections
for Pharmagest Interactive SA?

How accurate were the past EPS estimates
for Pharmagest Interactive SA?

What are the EBIT projections
for Pharmagest Interactive SA?

How accurate were the past EBIT estimates
for Pharmagest Interactive SA?

Compare the revenue forecasts
for Pharmagest Interactive SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pharmagest Interactive SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pharmagest Interactive SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pharmagest Interactive SA compared to its peers.

Compare the P/E ratios
of Pharmagest Interactive SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Pharmagest Interactive SA with its peers.

Analyze the financial leverage
of Pharmagest Interactive SA compared to its main competitors.

Show all profitability ratios
for Pharmagest Interactive SA.

Provide ROE
for Pharmagest Interactive SA.

Provide ROA
for Pharmagest Interactive SA.

Provide ROIC
for Pharmagest Interactive SA.

Provide ROCE
for Pharmagest Interactive SA.

Provide Gross Margin
for Pharmagest Interactive SA.

Provide Operating Margin
for Pharmagest Interactive SA.

Provide Net Margin
for Pharmagest Interactive SA.

Provide FCF Margin
for Pharmagest Interactive SA.

Show all solvency ratios
for Pharmagest Interactive SA.

Provide D/E Ratio
for Pharmagest Interactive SA.

Provide D/A Ratio
for Pharmagest Interactive SA.

Provide Interest Coverage Ratio
for Pharmagest Interactive SA.

Provide Altman Z-Score Ratio
for Pharmagest Interactive SA.

Provide Quick Ratio
for Pharmagest Interactive SA.

Provide Current Ratio
for Pharmagest Interactive SA.

Provide Cash Ratio
for Pharmagest Interactive SA.

What is the historical Revenue growth
over the last 5 years for Pharmagest Interactive SA?

What is the historical Net Income growth
over the last 5 years for Pharmagest Interactive SA?

What is the current Free Cash Flow
of Pharmagest Interactive SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pharmagest Interactive SA.

PHF

Income Statement

Income from Continuing Operations

Pharmagest Interactive SA
Income from Continuing Operations

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Pharmagest Interactive SA
Income from Continuing Operations Peer Comparison

Comparables:

CGM

EQS

ALMDT

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

	Income from Continuing Operations	CAGR 3Y	CAGR 5Y	CAGR 10Y
Pharmagest Interactive SA F:PHF	Income from Continuing Operations €47.7m	CAGR 3-Years 14%	CAGR 5-Years 12%	CAGR 10-Years 12%
Cegedim SA PAR:CGM	Income from Continuing Operations €1.8m	CAGR 3-Years -56%	CAGR 5-Years N/A	CAGR 10-Years N/A
Equasens SA PAR:EQS	Income from Continuing Operations €47.7m	CAGR 3-Years 14%	CAGR 5-Years 12%	CAGR 10-Years 12%
Median Technologies SA PAR:ALMDT	Income from Continuing Operations -€23m	CAGR 3-Years -22%	CAGR 5-Years -8%	CAGR 10-Years -18%

What is Pharmagest Interactive SA's Income from Continuing Operations?

Income from Continuing Operations
47.7m EUR

Based on the financial report for Dec 31, 2023, Pharmagest Interactive SA's Income from Continuing Operations amounts to 47.7m EUR.

What is Pharmagest Interactive SA's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
12%

Over the last year, the Income from Continuing Operations growth was -1%. The average annual Income from Continuing Operations growth rates for Pharmagest Interactive SA have been 14% over the past three years , 12% over the past five years , and 12% over the past ten years .

Pharmagest Interactive SA
F:PHF

Pharmagest Interactive SA
Income from Continuing Operations

Pharmagest Interactive SA
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

See Also

What is Pharmagest Interactive SA's Income from Continuing Operations?

Income from Continuing Operations
47.7m EUR

What is Pharmagest Interactive SA's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
12%

Company

Help

Tools

Stocks

Pharmagest Interactive SA F:PHF

Pharmagest Interactive SA Income from Continuing Operations

Pharmagest Interactive SA Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis Latest Figures & CAGR of Competitors

See Also

What is Pharmagest Interactive SA's Income from Continuing Operations? Income from Continuing Operations 47.7m EUR

What is Pharmagest Interactive SA's Income from Continuing Operations growth rate? Income from Continuing Operations CAGR 10Y 12%

Company

Help

Tools

Stocks

Pharmagest Interactive SA
F:PHF

Pharmagest Interactive SA
Income from Continuing Operations

Pharmagest Interactive SA
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

What is Pharmagest Interactive SA's Income from Continuing Operations?

Income from Continuing Operations
47.7m EUR

What is Pharmagest Interactive SA's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
12%